(Q44486778)

3 December 2017

Citalopram treatment of social anxiety disorder with comorbid major depression (English)

1 reference

3 December 2017

social anxiety disorder

1 reference

Carlos Blanco

2

0 references

author name string

Franklin R Schneier

1

1 reference

3 December 2017

Raphael Campeas

3

1 reference

3 December 2017

Roberto Lewis-Fernandez

4

1 reference

3 December 2017

Shu-Hsing Lin

5

1 reference

3 December 2017

Randall Marshall

6

1 reference

3 December 2017

Andrew B Schmidt

7

1 reference

3 December 2017

J Arturo Sanchez-Lacay

8

1 reference

3 December 2017

H Blair Simpson

9

1 reference

3 December 2017

Michael R Liebowitz

10

1 reference

3 December 2017

1 January 2003

1 reference

3 December 2017

Depression and Anxiety

1 reference

3 December 2017

17

1 reference

3 December 2017

4

1 reference

3 December 2017

191-196

1 reference

Paroxetine in social anxiety disorder: a randomized placebo-controlled study

3 December 2017

1 reference

7 January 2021

Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications

1 reference

7 January 2021

Psychotic symptoms in combat-related posttraumatic stress disorder

1 reference

7 January 2021

Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia

1 reference

7 January 2021

Anxiety disorders in major depression

1 reference

7 January 2021

Major depressive subtypes and treatment response.

1 reference

7 January 2021

Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression

1 reference

7 January 2021

A rating scale for depression

1 reference

7 January 2021

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

7 January 2021

Citalopram in the treatment of social phobia: a report of three cases

1 reference

7 January 2021

1 reference

7 January 2021

Social phobia. Review of a neglected anxiety disorder

1 reference

7 January 2021

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

1 reference

7 January 2021

Generalized social phobia. Reliability and validity

1 reference

7 January 2021

Implications of the severity of social phobia

1 reference

7 January 2021

Social phobia in a population-based female adolescent twin sample: co-morbidity and associated suicide-related symptoms

1 reference

7 January 2021

Atypical depression: a reappraisal

1 reference

7 January 2021

The influence of anxiety as a risk to early onset major depression

1 reference

7 January 2021

Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia

1 reference

7 January 2021

Partial validation of the atypical features subtype of major depressive disorder

1 reference

7 January 2021

Social phobia. Comorbidity and morbidity in an epidemiologic sample

1 reference

7 January 2021

Citalopram for social phobia: a clinical case series

1 reference

7 January 2021

Imipramine in the treatment of social phobia.

1 reference

7 January 2021

Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline

1 reference

7 January 2021

Predictors of response to pharmacotherapy in social anxiety disorder: an analysis of 3 placebo-controlled paroxetine trials.

1 reference

7 January 2021

Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults

1 reference

7 January 2021

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

1 reference

7 January 2021

Latent class analysis of lifetime depressive symptoms in the national comorbidity survey

1 reference

7 January 2021

Treatment of social anxiety disorder with citalopram

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.10112

1 reference

3 December 2017

1 reference